Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fate Therapeutics

1.04
-0.0400-3.70%
Post-market: 1.040.00000.00%18:22 EDT
Volume:869.54K
Turnover:906.97K
Market Cap:119.22M
PE:-0.70
High:1.08
Open:1.08
Low:1.02
Close:1.08
Loading ...
Aug 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 17, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Jun 04, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 30, 2025

Major Issues Report

Form 8-K - Current report
May 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 13, 2025

Major Issues Report

Form 8-K - Current report
Mar 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Jan 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 10, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 06, 2025

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 29, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Oct 25, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]